PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Curr Opin Pediatr. Author manuscript; available in PMC Apr 1, 2011.
Published in final edited form as:
PMCID: PMC2887611
NIHMSID: NIHMS203548
Environmental Exposures and Development
Donald R. Mattison
Donald R. Mattison, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland;
Mailing address: Donald R Mattison, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, Building 31, Room 1B44, Bethesda MD 20892, Phone 301 451 3823, mattisod/at/mail.nih.gov
Purpose of Review
Summarize recent studies exploring the relationship between paternal and maternal environmental exposures to chemicals before, at the time of and after conception to adverse developmental outcomes including; preterm birth, death, structural and functional abnormalities and growth restriction.
Recent Findings
Recent studies have demonstrated that human pregnancy and development is vulnerable to environmental exposures of the father and mother to chemical, biological and physical agents. Exposures associated with adverse developmental outcomes include; air and water pollution, chemicals in foods, occupational exposures, agricultural chemicals, metals, persistent and volatile organics. Developmental endpoints which are linked with these exposures include; growth restriction, functional abnormalities, structural abnormalities, preterm delivery and death. Despite this general understanding we still have incomplete knowledge concerning most exposures and the biological interactions responsible for impaired development and preterm delivery.
Summary
While single genes and individual chemical exposures are responsible for some instances of adverse pregnancy outcome or developmental disease, gene-environment interactions are responsible for the majority. These gene-environment interactions may occur in the father, mother, placenta or fetus suggesting that critical attention be given to maternal and paternal exposures and gene expression as they relate to the mode of action of the putative developmental toxicant both prior to and during pregnancy.
Keywords: Birth defects, developmental disability, fetal death, neonatal death, functional disability, growth impairment, occupational exposure, environmental exposure, chemical, biological, physical agents, gene-environment, development, life-course, maternal, paternal, air pollution, water pollution
Developmental diseases (fetal and neonatal death, structural alterations (birth defects), functional alterations, growth restriction and preterm delivery (1-3)) account for more than 25% of infant mortality and morbidity (2, 4, 5). The etiology of many developmental disorders is poorly understood, consequently, it is thought that infections, maternal or paternal health and genetic factors, drugs, over the counter medications, abused substances, environmental or occupational exposures are responsible (6-10).
This increases concern about maternal and paternal environmental exposures (5, 11, 12), and natural or terrorist inflicted disasters on pregnancy outcome and developmental health (13-17). Adding to these concerns have been publications evaluating the capabilities of surveillance systems in the United States to identify emerging developmental diseases (18, 19), and information on human body burdens of an enlarging list of chemicals, many suspect as developmental hazards (20)
Given these concerns it is important to understand the methods by which environmental exposures, genetic factors and adverse developmental outcomes have been assessed. This review summarizes recent selected publications from 2000 through 2009 concerning environmental chemical exposures and impact on human developmental outcomes.
Estimates of the etiology of developmental diseases (1, 21) have evolved as our understanding of developmental processes and environmental exposures has progressed (Table 1).
Table 1
Table 1
Estimates of the proportion of developmental disease by etiology.
It is clear that definitions used and duration of follow-up has substantial impact on infants identified as having a developmental disorder (24, 25). Initial work in experimental embryology and developmental biology used single agents to disrupt developmental processes, demonstrating vulnerability to a range of exposures (10). As our understanding of developmental biology and toxicology improved it was recognized that interactions between exposures and maternal/paternal health or fetal/placental genetic constitution could play a role (23, 26). While much still remains to be understood, current data suggests that developmental abnormalities are predominantly the result of biological-environmental interactions (27, 28). However, maternal or paternal genetic factors (23) as well as maternal or paternal (29, 30) exposures to developmental toxicants will still contribute to developmental disease (28, 31, 32)
Many surveys of developmental disease focus on assessment at birth, with attention to structural abnormalities and little attention to functional characteristics which can only be evaluated over time (33-36). Unfortunately, developmental disease characterized at birth only identifies ~1/3 of those with a structural abnormality (37-39), even those with life-threatening cardiovascular malformation (40) and will miss most functional abnormalities. Additionally, focusing on assessments at birth does not represent the impact of developmental disease over the life-course (24, 25, 41, 42).
A significant challenge in describing associations between environmental exposures and developmental outcomes is characterizing exposures as they relate to relevant developmental windows (43-47). For persistent chemicals such as dioxin, lead and organochlorine pesticides, fetal exposure can result from parental exposures prior to conception. Paternal exposures may contribute to fetal risk through mutagenic and epigenetic mechanisms involving the sperm, and the chemical can also be carried in semen (11, 30, 48).
Exposure characterization can be derived from questionnaire data, environmental monitoring, personal monitoring or measurement of exposures or metabolites in blood, hair, urine, or expired air. Improvements in exposure characterization is critical (49, 50) It is also essential to characterize biological factors in the pathways that influence disposition of, and response to the environmental pollutants.
Over the past decade there has been interest in personal monitoring, biomarkers and physiologically based models to refine exposure characterization. An example of use of a biomarker for monitoring PAH exposure during pregnancy is urinary 1-hydroxypyrine (51). Recently a detailed comparative analysis of physiologically based models has been conducted, and example utilized for characterizing drug exposure (52, 53).
Methods for defining prenatal exposure to flame retardants found in fabrics as well as other exposures, the class of chemicals called polybrominated diphenyl ethers (PBDEs) have been developed and the exposures during pregnancy and childhood summarized (54) This class of chemical is a concern because of diverse routes for exposures including indoor air, because body burdens of these lipid-soluble chemicals are greater in the North America than other regions of the world, and because of neurodevelopmental toxicity (55).
Exposures to polychlorinated biphenyls (PCB) are a concern for neurodevelopmental toxicity including; cognitive, motor and behavioral (56). One approach to define potential risk is analysis of body burdens of the PCBs among women of reproductive age (56) (20). Analysis of CDC data demonstrates the decrease in body burdens and suggests specific PCB congeners to follow with respect to prenatal exposure and potential developmental consequence.
Five health outcomes comprise the spectrum of developmental disorders: death, structural abnormalities, functional abnormalities, alteration of growth and preterm birth (1, 9, 57-59). (Table 2)
Table 2
Table 2
Developmental endpoints vulnerable to environmental disruption
Gestation length is included because rates of prematurity are increasing, there is evidence gestational length is altered by environmental exposures (3, 81-86), gestation length and developmental disease appear to have common causal pathways and it is a significant public health problem (82, 83).
The recognition that exposures early in life may influence expression of disease across the life course, including the prenatal origin of diseases has drawn attention to these various developmental disorders and focused attention on the relationships beyond birth (87-89). This review will focus on methods to determine if developmental disease which emerges across pregnancy, after birth and early in childhood is linked with environmental exposure.
Paternal Exposures and Abnormal Development
Analysis of environmental impacts on development tend to focus on maternal exposures; however animal and human evidence suggests that is inadequate (11, 29, 30, 90, 91). Currently it is clear that offspring are vulnerable to all endpoints of developmental toxicity following paternal exposures (92-95), however much work remains to be done to fully understand this relationship (30).
One challenge of studying environmental impacts on developmental health is that outcomes vary with definition and duration of follow-up (Table 3).
Table 3
Table 3
Developmental endpoints in pregnancy cohort studies and population surveys
One early assessment of prenatal influences on health and development was the British Perinatal Mortality Survey, conducted in 1958 (96). A similar birth-cohort study in the US, the Collaborative Perinatal Project (CPP), enrolled ~50,000 women from about the first trimester, through birth and followed their infants through 7 years of age (38, 98, 100, 101). Both studies demonstrated increased diagnosis of developmental disease with longer follow. Recently a dataset has been created and analyzed using a composite index of adverse developmental outcome (2).
Recently the CPP has explored relationships between; PCBs and hypospadias and cryptorchidism (102) (none observed); PBCs and gestation length (103) (none observed); PCBs and growth restriction (103) (weak association); theobromine and preeclampsia (104) (none observed), heptachlor epoxide, hexachlorobenzene and hexachlorocyclohexane and cryptorchidism (105) (none observed), DDE and prenatal (85) or postnatal growth (106) (inverse relationship observed), as well as body size in adolescent males (107) (no relationship observed); DDE and gestation length (85) (inverse association observed). Additional contributions have come from use of the data for biostatistical methods development; impact of previous reproductive history (108, 109), structural defects, polymorphisms in metabolizing enzymes and exposures (110) (association observed for some enzymes).
Environmental exposures associated with abnormal growth include; indoor air pollution from biomass fuel combustion (111) (questionnaire data); benzene (112). Exposure to particulates (PM2.5) and NO2 is associated with increased risk for growth restriction (113) (linked birth certificates with LMP and environmental monitoring data).
A survey of air pollutants (SO2, NO2, O3, CO and PM2.5) and impact on fetal growth was explored in three Canadian cities (Calgary, Edmonton, and Montreal) (114). Exposure was determined from air monitoring stations and birth data from vital statistics. The data suggested an inverse relationship between exposure to NO2, CO and PM2.5 and fetal growth. A similar study in Brisbane, Australia (115) measuring fetal growth and NO2, PM10 and O3 did not observe an inverse relationship between these pollutants and proxy measures for fetal growth (head circumference, crown-heel length, and small for gestational age). Differences in air pollutant composition may account for this as NO2 concentrations were higher in Canada and O3 concentrations higher in Brisbane.
Several studies have demonstrated ethnic differences in response to PAH and fetal growth (63), with growth and gestational length is inversely related to PAH exposure among African-Americans but not Dominicans in New York City. Studies with personal monitoring demonstrated an association with PAH and perinatal growth restriction (116, 117). While a study in S. Korea supports effects from exposures early in the pregnancy, a study in China finds a relationship only from exposures during the third trimester (118). Results from North America, where levels of pollution are lower, typically find an association between reduced birth weight and PM, but the findings are variable. Studies in California have found some association with PM, though in southern California not when adjusting for gaseous pollutants (119-121). There was no association between PM and low birth weight in a study in the northeastern United States (122), and a study in Canada found a small, but insignificant association with low levels of PM (123).
Collaborators in New York and Poland have contributed much to our understanding of air pollution and developmental disease. Recently they explored the role of prenatal particulate exposure (PM2.5) during pregnancy and growth (124) using personal exposure monitors. Previous work demonstrated that prenatal exposure to air pollutants is associated with growth impairment at birth (length, weight and head circumference), this work explored sex differences in response to prenatal exposure and growth. As PM2.5 levels increased fetal growth was impaired more in male than female fetus, other studies have suggested that the female was more sensitive to the effect of air pollution on birth weight, while males were more sensitive to effect of air pollution on preterm birth (125).
A study by Hansen explored ultrasound characterization of fetal growth in relationship to air pollution (126); femur length, abdominal circumference, head circumference and biparietal diameter. Air pollution exposures were monthly averages of PM10, SO2, NO2 and O3. This study demonstrates that as distance from the air monitoring station increases, adverse effect on fetal growth diminishes, reinforcing the benefit of personal monitoring and biomarkers of exposure.
Paternal exposures before pregnancy and maternal exposures before and during pregnancy to welding and metal fumes and dusts were associated with adverse pregnancy outcome. Paternal exposures may be associated with premature delivery and maternal exposures with impaired growth and prematurity (60) (exposures defined by questionnaire data and health outcomes by pregnancy records).
The Danish National Birth Cohort Study (DNBC) has evaluated maternal fatty fish consumption (127) exposure to PCBs, and fetal and placental growth (128). They observed that greater ingestion of fatty fish was associated with greater concentrations of PCBs and greater concentrations of PCBs was associated with impaired fetal and placental growth. The DNBC has also explored the association between the persistent organic pollutants perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) on fetal and placental growth (129) demonstrating an inverse association between PFOA and fetal growth.
Drinking water may contain diverse array of pollutants including products resulting from disinfection treatment. Studies using infrequent ecological exposure assessment have suggested adverse developmental consequences. A study collected water samples every week from the distribution system utilized by the subjects, and was unable to discern a relationship between drinking water exposures and developmental outcomes (130).
Over the past three decades, beginning with the research on lead and neurodevelopmental abnormalities greater attention has been given to functional abnormalities (74). Blood lead levels during pregnancy are associated with increased risks for pregnancy associated hypertension (131)), and ongoing research suggests that there is no threshold for fetal neurodevelopmental impacts (132) both cognitive and behavioral.
While it is clear that postnatal exposure to air pollution can alter pulmonary function, it is not know if similar exposures during pregnancy can alter pulmonary development and/or function in children later in life. A study by Latzin et al (133) explored this question using a birth cohort in Bern Switzerland and Swiss air pollution monitoring data, with lung function assessed at 5 weeks of age, demonstrating that PM10 exposure was associated with higher minute ventilation and tidal flows postnatally.
Airborne exposures to PAH are found in smoking and urbanized environments (134), and associated with reduced growth (63, 65, 135, 136) and shortened gestation (46). Analysis by Perera and colleagues extends the impact on functional deficits demonstrating an inverse relationship between PAH and IQ (134). Exposure to increased PAH concentrations following the World Trade Center terrorist incident altered neurocognitive development (137).
Prenatal mercury exposure (organic mercury, methyl mercury) has been known to be a developmental toxicant (producing cognitive, attention, behavior and motor alterations) for humans since the exposures in Minamata Japan in the 1950's as documented by the photographer W. Eugene Smith (138, 139). Prenatal mercury exposure is a concern because a common route is via fish, which also provides health benefits and it appears that there is no threshold for neurodevelopmental toxicity (140). However, the consequences of exposure to organic mercury may be modified by other environmental factors, including; diet, social factors, genetic constitution, exposure to other chemicals and lifestyle (141). An environmental chemical thought to interact with organic mercury in altering developmental consequences are the PCBs, themselves known to be developmental toxicants (55). In designing future studies it will be necessary to include these complex interactions as they will both buffer and exacerbate the adverse effects of many different chemical exposures on developmental endpoints.
Exposure to triazine and other herbicides, common contaminants of rural drinking water sources, may also lead to decreased fetal growth. An investigation of women living in a region of Iowa with raised levels of triazine, metolachlor, and cyanazine herbicides in the drinking water found that their offspring were more likely to suffer from growth restriction than infants born to women in other parts of the state (142). A Polish study similarly found that exposure to triazine herbicides in combination with other pesticides resulted in increased low birth weight rates, even when controlling for length of pregnancy (143). French researchers found that atrazine levels in municipal drinking water throughout pregnancy were not associated with increased risk of small-for-gestational age birth, but that the risk of SGA birth increased when the third trimester occurred in whole or in part during the period of May through September, when atrazine levels typically peak (84).
Structural abnormalities have traditionally been a focus of attention for abnormal pregnancy outcomes research, the idea that they may be related to gene-environmental interactions has become increasingly apparent, and adds to the complexity of experimental design (144, 145). In addition, the weight of evidence that air pollutants add to this burden of developmental disease is increasing (144, 146), although it is not always consistent (147). Maternal smoking has also been associated with clubfoot (148), tracheoesophageal-fistula (149, 150), renal agenesis (151). One especially interesting area has been the analysis of polymorphisms, smoking and structural malformations (152)
Analysis of prenatal exposure to SO2 and PM suggested relationships between PM and nervous system anomalies (146). Interestingly, structural abnormalities may increase following disasters (17). Paternal exposures during recent wars has been a concern with respect to birth defects, recent analysis suggests no impact on structural anomalies or pregnancy loss (153).
Cardiovascular defects are a common endpoint for environmental exposure studies (154-158). Occupational exposures of male electronics workers prior to conception has been associated with increased risk for cardiovascular defects (78). Maternal occupational exposure to nickel did not increase risk of defects but occupational exposure to copper did (159). Other maternal occupations which do not appear to increase risk for abnormal pregnancy outcome based on the DNBC studies include hairdressers (160), laboratory work (with the exception of those exposed to radioisotopes) (161), and gardening and farming (162). Other investigators have however suggested associations between maternal laboratory work and malformations (163).
Cardiovascular defects have been associated with air pollution (158, 164). Some studies have linked cardiovascular defects with maternal proximity to hazardous waste sites, but not all have observed that association (165), nor did proximity to municipal waste incinerators appear to be a risk factor for birth defects (166). Data from the Texas Birth Defects Registry found no association between hazardous waste sites and neural tube defects, but did observe an association between industrial sites and neural tube defects (167). Studies of trichloroethylene, a common water pollutant because of use as an industrial cleaning/degreasing agent suggests no relationship between exposure and cardiac defects (168).
There is conflicting evidence concerning preconception or pregnancy exposures to agricultural chemicals and birth defects; studies in Ontario suggest an association between preconception exposure to cyanazine or dicamba and defects in male offspring (169). Agricultural chemicals are found in surface water with seasonal variation, providing an opportunity for evaluation of the ecological relationship between surface water concentrations and developmental disease including birth defects (170). Studies exploring proximity to specific crops (corn, soybeans) have observed an increased risk of limb defects in proximity to cornfields, with no increased risk associated with proximity to soybean fields (171). Analysis of urban versus rural residence suggests atrial septal defects more common in rural areas (172), with other studies suggesting ventricular septal defects more common in rural areas (173).
Human exposures to environmental chemicals which interact with the endocrine systems (endocrine disrupting chemicals) prior to or during pregnancy are of concern because of the role these systems play in development. Paternal exposures to polychlorinated and phenolic compounds and maternal exposures to heavy metals and phthalates (174) alter the developing human reproductive systems. One concern is development of the reproductive system, including hypospadias (175), which may represent an interesting malformation for assessment of gene-environment interactions, and appears to be increasing (176).
Death
Early studies described a relationship between PM10 (particles less than or equal to 10um in size) or PM2.5 and postneonatal mortality (177) and prenatal growth restriction (117, 178). Exposure to PM in the North of England during the period 1962-1992 was not associated with the risk of stillbirth (179) (vital statistics and routine air monitoring data). PM10 was associated with increased postneonatal mortality and both PM sizes were associated with prenatal growth restriction; however chemical composition and individual exposures were not defined in these early studies.
Exposure to pesticides has been correlated with preterm birth and reduced fetal growth (8). A study of agricultural organophosphate pesticides found a significant positive association between maternal exposure and growth retardation (180). This finding is supported by studies of inner city and minority populations exposed to indoor pesticides; exposure to chlorpyrifos was inversely associated with birth weight (181), the inverse association between chlorpyrifos and birth weight was highly significant when limited to those born before the EPA banned residential use of this pesticide. Those born later had much lower exposure (182).
Studies of organophosphate metabolite levels and fetal growth have been less conclusive; a study of multiethnic mothers living in New York City found no relation (183), and a study of Latina women living in an agricultural area did not find (180). The latter study did find an association between exposure and preterm birth, most clearly related to increasing exposure levels in the later part of pregnancy (184).
Airborne exposures to PAH are found in smoking and urbanized environments (134), and associated with reduced growth (63, 65, 135, 136) and shortened gestation (46). Studies of preterm birth have found associations between preterm birth and PM in the Czech Republic (80), China (86), southern California, (119), Pennsylvania, (185), and California (186). The associations tend to be relatively small, though typically statistically significant (8).
Maternal and paternal environmental exposures can produce human developmental disease including; preterm birth, growth restriction, functional or structural abnormalities or death. Our understanding of developmental diseases is changing; we recognize that environmental exposures during development can be expressed across the life of the individual, into adulthood (187). In addition, we now know that paternal exposures can result in developmental disease in their offspring (11, 29). Of greatest concern, however, is the growing recognition that functional impacts of environmental exposures may not have thresholds (132). This means that the only reasonable approach is to keep environmental exposures for all individuals as low as possible.
Acknowledgments
Funding: Funding for this work has been provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute of Health.
Footnotes
Conflicts: DRM has no financial interests or potential conflicts of interests to disclose
This paper was prepared by an employee of the US Government making this a “work of the US Government” and therefore copyright is non-transferrable.
Disclaimer: The opinions stated in this chapter are those of the author and do not necessarily represent the views of the Department of Health and Human Services, the National Institutes of Health or the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
1. Schaefer C, Peters P, Miller RK, editors. Drugs During Pregnancy and Lactation Treatment options and risk assessment Second Edition. Second Edition. Amsterdam: Elsevier; 2007.
2. Liu X, Roth J. Development and validation of an infant morbidity index using latent variable models. Stat Med. 2008 Mar 30;27(7):971–89. [PubMed]
3. Mattison DR, Wilson S, Coussens C, Gilbert D, editors. The Role of Environmental Hazards in Premature Birth. Washington, D.C.: The National Academies Press; 2003.
4. Copeland GE, Kirby RS. Using birth defects registry data to evaluate infant and childhood mortality associated with birth defects: an alternative to traditional mortality assessment using underlying cause of death statistics. Birth Defects Res A Clin Mol Teratol. 2007 Nov;79(11):792–7. [PubMed]
5. Stillerman KP, Mattison DR, Giudice LC, Woodruff TJ. Environmental exposures and adverse pregnancy outcomes: a review of the science. Reprod Sci. 2008 Sep;15(7):631–50. [PubMed]
6. Brent RL. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics. 2004 Apr;113(4 Suppl):957–68. [PubMed]
7. Shepard TH, Lemire RJ. Catalog of teratogenic agents. 12th Edition. Baltimore: The Johns Hopkins University Press; 2007.
8. Wigle DT, Arbuckle TE, Turner MC, Berube A, Yang Q, Liu S, et al. Epidemiologic evidence of relationships between reproductive and child health outcomes and environmental chemical contaminants. J Toxicol Environ Health B Crit Rev. 2008 May;11(5-6):373–517. [PubMed]
9. Schardein JL. Chemically Induced Birth Defects. Third Edition, Revised and Expanded. New York: Marcel Dekker; 2000.
10. Kalter H. Teratology in the 20th century: Environmental causes of congenital malformations in humans and how they were established. Neurotoxicology and Teratology. 2003;25(2):131–282. [PubMed]
11. Cordier S. Evidence for a role of paternal exposures in developmental toxicity. Basic Clin Pharmacol Toxicol. 2008 Feb;102(2):176–81. [PubMed]
12. Woodruff TJ, Parker JD, Darrow LA, Slama R, Bell ML, Choi H, et al. Methodological issues in studies of air pollution and reproductive health. Environ Res. 2009 Feb 10; [PubMed]
13. Xiong X, Harville EW, Mattison DR, Elkind-Hirsch K, Pridjian G, Buekens P. Exposure to Hurricane Katrina, post-traumatic stress disorder and birth outcomes. Am J Med Sci. 2008 Aug;336(2):111–5. [PMC free article] [PubMed]
14. Quinn D, Lavigne SV, Chambers C, Wolfe L, Chipman H, Cragan JD, et al. Addressing concerns of pregnant and lactating women after the 2005 hurricanes: the OTIS response. MCN Am J Matern Child Nurs. 2008 Jul-Aug;33(4):235–41. [PubMed]
15. Joss-Moore LA, Lane RH. The developmental origins of adult disease. Curr Opin Pediatr. 2009 Apr;21(2):230–4. [PMC free article] [PubMed]
16. Simmons RA. Developmental origins of adult disease. Pediatr Clin North Am. 2009 Jun;56(3):449–66. Table of Contents. [PMC free article] [PubMed]
17. Tan CE, Li HJ, Zhang XG, Zhang H, Han PY, An Q, et al. The impact of the Wenchuan earthquake on birth outcomes. PLoS One. 2009;4(12):e8200. [PMC free article] [PubMed]
18. Elliott K, Segal LM, Juliano C, Mandel J, Hearne SA. Birth Defects and Developmental Disabilities: The Search for Causes and Cures. Issue Report [serial on the Internet] 2005. Available from: www.healthyamericans.org.
19. Locke PA, Koduru S, Edmunds M, Yingvorapant E, Dillingham A, Goffe A. Birth Defects Tracking and Prevention: Too Many States are Not Making the Grade. 2002. Available from: www.healthyamericans.org.
20. CDC N. Human Exposure to Environmental Chemicals Fourth Report. Atlanta Georga: Department of Health and Human Services, Centers for Disease Control and Prevention; 2009.
21. Wilson JG. Present status of drugs as teratogens in man. Teratology. 1973 Feb;7(1):3–15. [PubMed]
22. Brent RL. Teratology in the 20th century environmental causes of congenital malformations in humans and how they were established. Neurotoxicol Teratol. 2004 Jan-Feb;26(1):1–12. [PubMed]
23. Nelson K, Holmes LB. Malformations due to presumed spontaneous mutations in newborn infants. N Engl J Med. 1989 Jan 5;320(1):19–23. [PubMed]
24. Tomson T. Which drug for the pregnant woman with epilepsy? N Engl J Med. 2009 Apr 16;360(16):1667–9. [PubMed]
25. Meador KJ, Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, et al. Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. N Engl J Med. 2009 Apr 16;360(16):1597–605. [PMC free article] [PubMed]
26. Godwin KA, Sibbald B, Bedard T, Kuzeljevic B, Lowry RB, Arbour L. Changes in frequencies of select congenital anomalies since the onset of folic acid fortification in a Canadian birth defect registry. Can J Public Health. 2008 Jul-Aug;99(4):271–5. [PubMed]
27. Perera FP, Rauh V, Whyatt RM, Tsai WY, Bernert JT, Tu YH, et al. Molecular evidence of an interaction between prenatal environmental exposures and birth outcomes in a multiethnic population. Environ Health Perspect. 2004 Apr;112(5):626–30. [PMC free article] [PubMed]
28. Zeiger JS, Beaty TH, Liang KY. Oral clefts, maternal smoking, and TGFA: a meta-analysis of gene-environment interaction. Cleft Palate Craniofac J. 2005 Jan;42(1):58–63. [PubMed]
29. Anderson D. Male-mediated developmental toxicity. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):506–13. [PubMed]
30. Anderson D, Brinkworth M, editors. International Conference on Male-Mediated Developmental Toxicity; Cambridge, UK: RSC Publishing; 2007.
31. Anum EA, Springel EH, Shriver MD, Strauss JF., 3rd Genetic contributions to disparities in preterm birth. Pediatr Res. 2009 Jan;65(1):1–9. [PMC free article] [PubMed]
32. Lidral AC, Moreno LM, Bullard SA. Genetic Factors and Orofacial Clefting. Semin Orthod. 2008 Jun;14(2):103–14. [PMC free article] [PubMed]
33. Colborn T. A case for revisiting the safety of pesticides: a closer look at neurodevelopment. Environ Health Perspect. 2006 Jan;114(1):10–7. [PMC free article] [PubMed]
34. Mendola P, Selevan SG, Gutter S, Rice D. Environmental factors associated with a spectrum of neurodevelopmental deficits. Ment Retard Dev Disabil Res Rev. 2002;8(3):188–97. [PubMed]
35. Perera FP, Rauh V, Whyatt RM, Tsai WY, Tang D, Diaz D, et al. Effect of prenatal exposure to airborne polycyclic aromatic hydrocarbons on neurodevelopment in the first 3 years of life among inner-city children. Environ Health Perspect. 2006 Aug;114(8):1287–92. [PMC free article] [PubMed]
36. Rauh VA, Garfinkel R, Perera FP, Andrews HF, Hoepner L, Barr DB, et al. Impact of prenatal chlorpyrifos exposure on neurodevelopment in the first 3 years of life among inner-city children. Pediatrics. 2006 Dec;118(6):e1845–59. [PMC free article] [PubMed]
37. Leck I, Record RG, McKeown T, Edwards JH. The incidence of malformations in Birmingham, England, 1950-1959. Teratology. 1968 Aug;1(3):263–80. [PubMed]
38. Myrianthopolous NC. Malformations in Children from one to Seven Years A report from the collaborative perinatal project. New York: Alan R. Liss; 1985.
39. Christianson RE, van den Berg BJ, Milkovich L, Oechsli FW. Incidence of congenital anomalies among white and black live births with long-term follow-up. Am J Public Health. 1981 Dec;71(12):1333–41. [PubMed]
40. Wren C, Reinhardt Z, Khawaja K. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed. 2008 Jan;93(1):F33–5. [PubMed]
41. Wadhwa PD, Buss C, Entringer S, Swanson JM. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med. 2009 Sep;27(5):358–68. [PMC free article] [PubMed]
42. Susser E, St Clair D, He L. Latent effects of prenatal malnutrition on adult health: the example of schizophrenia. Ann N Y Acad Sci. 2008;1136:185–92. [PubMed]
43. Whyatt RM, Garfinkel R, Hoepner LA, Andrews H, Holmes D, Williams MK, et al. A biomarker validation study of prenatal chlorpyrifos exposure within an inner-city cohort during pregnancy. Environ Health Perspect. 2009 Apr;117(4):559–67. [PMC free article] [PubMed]
44. Swanson JM, Entringer S, Buss C, Wadhwa PD. Developmental origins of health and disease: environmental exposures. Semin Reprod Med. 2009 Sep;27(5):391–402. [PMC free article] [PubMed]
45. Suh YJ, Kim H, Seo JH, Park H, Kim YJ, Hong YC, et al. Different effects of PM10 exposure on preterm birth by gestational period estimated from time-dependent survival analyses. Int Arch Occup Environ Health. 2009 Apr;82(5):613–21. [PubMed]
46. Naufal Z, Zhiwen L, Zhu L, Zhou GD, McDonald T, He LY, et al. Biomarkers of exposure to combustion by-products in a human population in Shanxi, China. J Expo Sci Environ Epidemiol. 2009 Mar 11; [PubMed]
47. Chen L, Bell EM, Caton AR, Druschel CM, Lin S. Residential mobility during pregnancy and the potential for ambient air pollution exposure misclassification. Environ Res. 2009 Dec 4; [PubMed]
48. Yang Q, Wen SW, Leader A, Chen XK, Lipson J, Walker M. Paternal age and birth defects: how strong is the association? Hum Reprod. 2007 Mar;22(3):696–701. [PubMed]
49. Windham G, Fenster L. Environmental contaminants and pregnancy outcomes. Fertil Steril. 2008 Feb;89(2 Suppl):e111–6. discussion e7. [PubMed]
50. Slama R, Darrow L, Parker J, Woodruff TJ, Strickland M, Nieuwenhuijsen M, et al. Meeting report: atmospheric pollution and human reproduction. Environ Health Perspect. 2008 Jun;116(6):791–8. [PMC free article] [PubMed]
51. Llop S, Ballester F, Estarlich M, Ibarluzea J, Manrique A, Rebagliato M, et al. Urinary 1-hydroxypyrene, air pollution exposure and associated life style factors in pregnant women. Sci Total Environ. 2008 Dec 15;407(1):97–104. [PubMed]
52. Corley RA, Mast TJ, Carney EW, Rogers JM, Daston GP. Evaluation of physiologically based models of pregnancy and lactation for their application in children's health risk assessments. Crit Rev Toxicol. 2003;33(2):137–211. [PubMed]
53. Andrew MA, Hebert MF, Vicini P. Physiologically based pharmacokinetic model of midazolam disposition during pregnancy. Conf Proc IEEE Eng Med Biol Soc. 2008;2008:5454–7. [PubMed]
54. Frederiksen M, Vorkamp K, Thomsen M, Knudsen LE. Human internal and external exposure to PBDEs--a review of levels and sources. Int J Hyg Environ Health. 2009 Mar;212(2):109–34. [PubMed]
55. Roze E, Meijer L, Bakker A, Van Braeckel KN, Sauer PJ, Bos AF. Prenatal Exposure to Organohalogens, Including Brominated Flame Retardants, Influences Motor, Cognitive, and Behavioral Performance at School Age. Environ Health Perspect. 2009 Dec;117(12):1953–8. [PMC free article] [PubMed]
56. Axelrad DA, Goodman S, Woodruff TJ. PCB body burdens in US women of childbearing age 2001-2002: An evaluation of alternate summary metrics of NHANES data. Environ Res. 2009 May;109(4):368–78. [PubMed]
57. Goldey ES, Tilson HA, Crofton KM. Implications of the use of neonatal birth weight, growth, viability, and survival data for predicting developmental neurotoxicity: a survey of the literature. Neurotoxicol Teratol. 1995 May-Jun;17(3):313–32. [PubMed]
58. Tabacova S, Kimmel CA, Wall K, Hansen D. Atenolol developmental toxicity: animal-to-human comparisons. Birth Defects Res A Clin Mol Teratol. 2003 Mar;67(3):181–92. [PubMed]
59. McKeown T, Record RG. Early environmental influences on the development of intelligence. Br Med Bull. 1971 Jan;27(1):48–52. [PubMed]
60. Quansah R, Jaakkola JJ. Paternal and maternal exposure to welding fumes and metal dusts or fumes and adverse pregnancy outcomes. Int Arch Occup Environ Health. 2009 Mar;82(4):529–37. [PubMed]
61. Parker JD, Woodruff TJ. Influences of study design and location on the relationship between particulate matter air pollution and birthweight. Paediatr Perinat Epidemiol. 2008 May;22(3):214–27. [PubMed]
62. Nembhard WN, Loscalzo ML. Fetal growth among infants with congenital heart defects by maternal race/ethnicity. Ann Epidemiol. 2009 May;19(5):311–5. [PubMed]
63. Choi H, Rauh V, Garfinkel R, Tu Y, Perera FP. Prenatal exposure to airborne polycyclic aromatic hydrocarbons and risk of intrauterine growth restriction. Environ Health Perspect. 2008 May;116(5):658–65. [PMC free article] [PubMed]
64. Malik S, Cleves MA, Zhao W, Correa A, Hobbs CA. Association between congenital heart defects and small for gestational age. Pediatrics. 2007 Apr;119(4):e976–82. [PubMed]
65. Choi H, Jedrychowski W, Spengler J, Camann DE, Whyatt RM, Rauh V, et al. International studies of prenatal exposure to polycyclic aromatic hydrocarbons and fetal growth. Environ Health Perspect. 2006 Nov;114(11):1744–50. [PMC free article] [PubMed]
66. Whyatt RM, Camann D, Perera FP, Rauh VA, Tang D, Kinney PL, et al. Biomarkers in assessing residential insecticide exposures during pregnancy and effects on fetal growth. Toxicol Appl Pharmacol. 2005 Aug 7;206(2):246–54. [PubMed]
67. Wilcox AJ. On the importance--and the unimportance--of birthweight. Int J Epidemiol. 2001 Dec;30(6):1233–41. [PubMed]
68. Tyl RW, Crofton K, Moretto A, Moser V, Sheets LP, Sobotka TJ. Identification and interpretation of developmental neurotoxicity effects: a report from the ILSI Research Foundation/Risk Science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol Teratol. 2008 Jul-Aug;30(4):349–81. [PubMed]
69. Makris SL, Raffaele K, Allen S, Bowers WJ, Hass U, Alleva E, et al. A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ Health Perspect. 2009 Jan;117(1):17–25. [PMC free article] [PubMed]
70. Bjorling-Poulsen M, Andersen HR, Grandjean P. Potential developmental neurotoxicity of pesticides used in Europe. Environ Health. 2008;7:50. [PMC free article] [PubMed]
71. Woolf AD, Goldman R, Bellinger DC. Update on the clinical management of childhood lead poisoning. Pediatr Clin North Am. 2007 Apr;54(2):271–94. viii. [PubMed]
72. Bellinger DC. Lead. Pediatrics. 2004 Apr;113(4 Suppl):1016–22. [PubMed]
73. Bellinger DC. Teratogen update: Lead and pregnancy. Birth Defects Research Part A: Clinical and Molecular Teratology. 2005;73(6):409–20. [PubMed]
74. Wells PG, McCallum GP, Chen CS, Henderson JT, Lee CJ, Perstin J, et al. Oxidative stress in developmental origins of disease: teratogenesis, neurodevelopmental deficits, and cancer. Toxicol Sci. 2009 Mar;108(1):4–18. [PubMed]
75. Hemachandra AH, Klebanoff MA, Duggan AK, Hardy JB, Furth SL. The association between intrauterine growth restriction in the full-term infant and high blood pressure at age 7 years: results from the Collaborative Perinatal Project. Int J Epidemiol. 2006 Aug;35(4):871–7. [PubMed]
76. Friedman JM, Polifka J. Teratogenic Effects of Drugs A Resource for Clinicians (TERIS) Second Edition. Baltimore: The Johns Hopkins University Press; 2000.
77. Sever JL. Infections in pregnancy: highlights from the collaborative perinatal project. Teratology. 1982 Apr;25(2):227–37. [PubMed]
78. Sung TI, Wang JD, Chen PC. Increased risks of infant mortality and of deaths due to congenital malformation in the offspring of male electronics workers. Birth Defects Res A Clin Mol Teratol. 2009 Feb;85(2):119–24. [PubMed]
79. Weselak M, Arbuckle TE, Walker MC, Krewski D. The influence of the environment and other exogenous agents on spontaneous abortion risk. J Toxicol Environ Health B Crit Rev. 2008 Mar;11(3-4):221–41. [PubMed]
80. Bobak M. Outdoor air pollution, low birth weight, and prematurity. Environ Health Perspect. 2000 Feb;108(2):173–6. [PMC free article] [PubMed]
81. Kramer MR, Hogue CR. What causes racial disparities in very preterm birth? A biosocial perspective. Epidemiol Rev. 2009;31:84–98. [PubMed]
82. Honein MA, Kirby RS, Meyer RE, Xing J, Skerrette NI, Yuskiv N, et al. The association between major birth defects and preterm birth. Matern Child Health J. 2009 Mar;13(2):164–75. [PubMed]
83. Parker JD, Mendola P, Woodruff TJ. Preterm birth after the Utah Valley Steel Mill closure: a natural experiment. Epidemiology. 2008 Nov;19(6):820–3. [PubMed]
84. Villanueva CM, Durand G, Coutte MB, Chevrier C, Cordier S. Atrazine in municipal drinking water and risk of low birth weight, preterm delivery, and small-for-gestational-age status. Occup Environ Med. 2005 Jun;62(6):400–5. [PMC free article] [PubMed]
85. Longnecker MP, Klebanoff MA, Zhou H, Brock JW. Association between maternal serum concentration of the DDT metabolite DDE and preterm and small-for-gestational-age babies at birth. Lancet. 2001 Jul 14;358(9276):110–4. [PubMed]
86. Xu X, Ding H, Wang X. Acute effects of total suspended particles and sulfur dioxides on preterm delivery: a community-based cohort study. Arch Environ Health. 1995 Nov-Dec;50(6):407–15. [PubMed]
87. Berkman LF. Social epidemiology: social determinants of health in the United States: are we losing ground? Annu Rev Public Health. 2009 Apr 29;30:27–41. [PubMed]
88. Mathers JC, McKay JA. Epigenetics - potential contribution to fetal programming. Adv Exp Med Biol. 2009;646:119–23. [PubMed]
89. Wise PH. Confronting social disparities in child health: a critical appraisal of life-course science and research. Pediatrics. 2009 Nov;124 3:S203–11. [PubMed]
90. Robaire B, Hales BF. Advances in male mediated developmental toxicity. New York: Kluwer Academic/Plenum Pub.; 2003.
91. Olshan AF, Mattison DR. Male-mediated developmental toxicity. New York: Plenum Press; 1994.
92. Somers CM, Cooper DN. Air pollution and mutations in the germline: are humans at risk? Hum Genet. 2009 Mar;125(2):119–30. [PubMed]
93. Yauk C, Polyzos A, Rowan-Carroll A, Somers CM, Godschalk RW, Van Schooten FJ, et al. Germ-line mutations, DNA damage, and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial location. Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):605–10. [PubMed]
94. Somers CM, McCarry BE, Malek F, Quinn JS. Reduction of particulate air pollution lowers the risk of heritable mutations in mice. Science. 2004 May 14;304(5673):1008–10. [PubMed]
95. Somers CM, Yauk CL, White PA, Parfett CL, Quinn JS. Air pollution induces heritable DNA mutations. Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):15904–7. [PubMed]
96. Butler NR, Bonham DG. Perinatal Mortality. The first report of the 1958 British perinatal mortality survey under the auspices off the National Birthday Trust. Edinburgh and London: E and S Livingstone, LTD; 1963.
97. Davie R, Butler N, Goldstein H. From Birth to Seven. With full statistical appendix. London: Longman; 1972.
98. Niswander KR, Gordon M. The women and their pregnancies. The collaborative perinatal study of the National Institute of Neurological Disease and Stroke. Washington DC: US Department of Health Education and Welfare, Public Health Service, DHEW Publication (NIH); 1972. pp. 73–379.
99. Heinonen OP, Slone D, Shapiro S. Birth Defects and Drugs in Pregnancy. Littleton, MA: Publishing Sciences Group, Inc.; 1977.
100. Hardy JB. The Collaborative Perinatal Project: lessons and legacy. Ann Epidemiol. 2003 May;13(5):303–11. [PubMed]
101. Klebanoff MA. The Collaborative Perinatal Project: a 50-year retrospective. Paediatr Perinat Epidemiol. 2009 Jan;23(1):2–8. [PMC free article] [PubMed]
102. McGlynn KA, Guo X, Graubard BI, Brock JW, Klebanoff MA, Longnecker MP. Maternal pregnancy levels of polychlorinated biphenyls and risk of hypospadias and cryptorchidism in male offspring. Environ Health Perspect. 2009 Sep;117(9):1472–6. [PMC free article] [PubMed]
103. Longnecker MP, Klebanoff MA, Brock JW, Guo X. Maternal levels of polychlorinated biphenyls in relation to preterm and small-for-gestational-age birth. Epidemiology. 2005 Sep;16(5):641–7. [PubMed]
104. Klebanoff MA, Zhang J, Zhang C, Levine RJ. Maternal serum theobromine and the development of preeclampsia. Epidemiology. 2009 Sep;20(5):727–32. [PubMed]
105. Pierik FH, Klebanoff MA, Brock JW, Longnecker MP. Maternal pregnancy serum level of heptachlor epoxide, hexachlorobenzene, and beta-hexachlorocyclohexane and risk of cryptorchidism in offspring. Environ Res. 2007 Nov;105(3):364–9. [PMC free article] [PubMed]
106. Ribas-Fito N, Gladen BC, Brock JW, Klebanoff MA, Longnecker MP. Prenatal exposure to 1,1-dichloro-2,2-bis (p-chlorophenyl)ethylene (p,p′-DDE) in relation to child growth. Int J Epidemiol. 2006 Aug;35(4):853–8. [PubMed]
107. Gladen BC, Klebanoff MA, Hediger ML, Katz SH, Barr DB, Davis MD, et al. Prenatal DDT exposure in relation to anthropometric and pubertal measures in adolescent males. Environ Health Perspect. 2004 Dec;112(17):1761–7. [PMC free article] [PubMed]
108. Howards PP, Schisterman EF, Heagerty PJ. Potential confounding by exposure history and prior outcomes: an example from perinatal epidemiology. Epidemiology. 2007 Sep;18(5):544–51. [PubMed]
109. Louis GB, Dukic V, Heagerty PJ, Louis TA, Lynch CD, Ryan LM, et al. Analysis of repeated pregnancy outcomes. Stat Methods Med Res. 2006 Apr;15(2):103–26. [PubMed]
110. Azzato EM, Chen RA, Wacholder S, Chanock SJ, Klebanoff MA, Caporaso NE. Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations. Pharmacogenet Genomics. Jan;20(1):58–63. [PubMed]
111. Tielsch JM, Katz J, Thulasiraj RD, Coles CL, Sheeladevi S, Yanik EL, et al. Exposure to indoor biomass fuel and tobacco smoke and risk of adverse reproductive outcomes, mortality, respiratory morbidity and growth among newborn infants in south India. Int J Epidemiol. 2009 Oct;38(5):1351–63. [PubMed]
112. Slama R, Thiebaugeorges O, Goua V, Aussel L, Sacco P, Bohet A, et al. Maternal personal exposure to airborne benzene and intrauterine growth. Environ Health Perspect. 2009 Aug;117(8):1313–21. [PMC free article] [PubMed]
113. Rich DQ, Demissie K, Lu SE, Kamat L, Wartenberg D, Rhoads GG. Ambient air pollutant concentrations during pregnancy and the risk of fetal growth restriction. J Epidemiol Community Health. 2009 Jun;63(6):488–96. [PubMed]
114. Liu S, Krewski D, Shi Y, Chen Y, Burnett RT. Association between maternal exposure to ambient air pollutants during pregnancy and fetal growth restriction. J Expo Sci Environ Epidemiol. 2007 Aug;17(5):426–32. [PubMed]
115. Hansen C, Neller A, Williams G, Simpson R. Low levels of ambient air pollution during pregnancy and fetal growth among term neonates in Brisbane, Australia. Environ Res. 2007 Mar;103(3):383–9. [PubMed]
116. Dejmek J, Solansky I, Benes I, Lenicek J, Sram RJ. The impact of polycyclic aromatic hydrocarbons and fine particles on pregnancy outcome. Environ Health Perspect. 2000 Dec;108(12):1159–64. [PMC free article] [PubMed]
117. Jedrychowski W, Bendkowska I, Flak E, Penar A, Jacek R, Kaim I, et al. Estimated risk for altered fetal growth resulting from exposure to fine particles during pregnancy: an epidemiologic prospective cohort study in Poland. Environ Health Perspect. 2004 Oct;112(14):1398–402. [PMC free article] [PubMed]
118. Wang X, Ding H, Ryan L, Xu X. Association between air pollution and low birth weight: a community- based study. Environ Health Perspect. 1997;105(5):514–20. [PMC free article] [PubMed]
119. Wilhelm M, Ritz B. Local variations in CO and particulate air pollution and adverse birth outcomes in Los Angeles County, California, USA. Environ Health Perspect. 2005 Sep;113(9):1212–21. [PMC free article] [PubMed]
120. Salam MT, Millstein J, Li YF, Lurmann FW, Margolis HG, Gilliland FD. Birth outcomes and prenatal exposure to ozone, carbon monoxide, and particulate matter: results from the Children's Health Study. Environ Health Perspect. 2005 Nov;113(11):1638–44. [PMC free article] [PubMed]
121. Parker JD, Woodruff TJ, Basu R, Schoendorf KC. Air pollution and birth weight among term infants in California. Pediatrics. 2005 Jan;115(1):121–8. [PubMed]
122. Maisonet M, Bush T, Correa A, Jaakkola J. Relation between ambient air pollution and low birth weight in the northeastern United States. Environ Health Perspect. 2001;109(Supplement 3):351–6. [PMC free article] [PubMed]
123. Dugandzic R, Dodds L, Stieb D, Smith-Doiron M. The association between low level exposures to ambient air pollution and term low birth weight: a retrospective cohort study. Environ Health. 2006;5:3. [PMC free article] [PubMed]
124. Jedrychowski W, Perera F, Mrozek-Budzyn D, Mroz E, Flak E, Spengler JD, et al. Gender differences in fetal growth of newborns exposed prenatally to airborne fine particulate matter. Environ Res. 2009 May;109(4):447–56. [PubMed]
125. Ghosh R, Rankin J, Pless-Mulloli T, Glinianaia S. Does the effect of air pollution on pregnancy outcomes differ by gender? A systematic review. Environ Res. 2007 Nov;105(3):400–8. [PubMed]
126. Hansen CA, Barnett AG, Pritchard G. The effect of ambient air pollution during early pregnancy on fetal ultrasonic measurements during mid-pregnancy. Environ Health Perspect. 2008 Mar;116(3):362–9. [PMC free article] [PubMed]
127. Halldorsson TI, Meltzer HM, Thorsdottir I, Knudsen V, Olsen SF. Is high consumption of fatty fish during pregnancy a risk factor for fetal growth retardation? A study of 44,824 Danish pregnant women. Am J Epidemiol. 2007 Sep 15;166(6):687–96. [PubMed]
128. Halldorsson TI, Thorsdottir I, Meltzer HM, Nielsen F, Olsen SF. Linking exposure to polychlorinated biphenyls with fatty fish consumption and reduced fetal growth among Danish pregnant women: a cause for concern? Am J Epidemiol. 2008 Oct 15;168(8):958–65. [PubMed]
129. Fei C, McLaughlin JK, Tarone RE, Olsen J. Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. Am J Epidemiol. 2008 Jul 1;168(1):66–72. [PubMed]
130. Hoffman CS, Mendola P, Savitz DA, Herring AH, Loomis D, Hartmann KE, et al. Drinking water disinfection by-product exposure and fetal growth. Epidemiology. 2008 Sep;19(5):729–37. [PubMed]
131. Yazbeck C, Thiebaugeorges O, Moreau T, Goua V, Debotte G, Sahuquillo J, et al. Maternal blood lead levels and the risk of pregnancy-induced hypertension: the EDEN cohort study. Environ Health Perspect. 2009 Oct;117(10):1526–30. [PMC free article] [PubMed]
132. Wigle DT, Lanphear BP. Human health risks from low-level environmental exposures: no apparent safety thresholds. PLoS Med. 2005 Dec;2(12):e350. [PMC free article] [PubMed]
133. Latzin P, Roosli M, Huss A, Kuehni CE, Frey U. Air pollution during pregnancy and lung function in newborns: a birth cohort study. Eur Respir J. 2009 Mar;33(3):594–603. [PubMed]
134. Perera FP, Li Z, Whyatt R, Hoepner L, Wang S, Camann D, et al. Prenatal airborne polycyclic aromatic hydrocarbon exposure and child IQ at age 5 years. Pediatrics. 2009 Aug;124(2):e195–202. [PMC free article] [PubMed]
135. Perera FP, Tang D, Rauh V, Lester K, Tsai WY, Tu YH, et al. Relationships among polycyclic aromatic hydrocarbon-DNA adducts, proximity to the World Trade Center, and effects on fetal growth. Environ Health Perspect. 2005 Aug;113(8):1062–7. [PMC free article] [PubMed]
136. Perera FP, Rauh V, Whyatt RM, Tang D, Tsai WY, Bernert JT, et al. A summary of recent findings on birth outcomes and developmental effects of prenatal ETS, PAH, and pesticide exposures. Neurotoxicology. 2005 Aug;26(4):573–87. [PubMed]
137. Perera FP, Tang D, Rauh V, Tu YH, Tsai WY, Becker M, et al. Relationship between polycyclic aromatic hydrocarbon-DNA adducts, environmental tobacco smoke, and child development in the World Trade Center cohort. Environ Health Perspect. 2007 Oct;115(10):1497–502. [PMC free article] [PubMed]
138. Wilcox AJ, Savitz DA, Samet JM. A tale of two toxicants: lessons from Minamata and Liaoning. Epidemiology. 2008 Jan;19(1):1–2. [PubMed]
139. Matsumoto H, Koya G, Takeuchi T. Fetal Minamata disease. A neuropathological study of two cases of intrauterine intoxication by a methyl mercury compound. J Neuropathol Exp Neurol. 1965 Oct;24(4):563–74. [PubMed]
140. Axelrad DA, Bellinger DC, Ryan LM, Woodruff TJ. Dose-response relationship of prenatal mercury exposure and IQ: an integrative analysis of epidemiologic data. Environ Health Perspect. 2007 Apr;115(4):609–15. [PMC free article] [PubMed]
141. Rice DC. Overview of modifiers of methylmercury neurotoxicity: chemicals, nutrients, and the social environment. Neurotoxicology. 2008 Sep;29(5):761–6. [PubMed]
142. Munger R, Isacson P, Hu S, Burns T, Hanson J, Lynch CF, et al. Intrauterine growth retardation in Iowa communities with herbicide-contaminated drinking water supplies. Environ Health Perspect. 1997 Mar;105(3):308–14. [PMC free article] [PubMed]
143. Dabrowski S, Hanke W, Polanska K, Makowiec-Dabrowska T, Sobala W. Pesticide exposure and birthweight: an epidemiological study in Central Poland. Int J Occup Med Environ Health. 2003;16(1):31–9. [PubMed]
144. Ritz B. Air-pollution and congenital anomalies. Occup Environ Med. 2009 Nov 2;
145. Shaw GM, Selvin S, Carmichael SL, Schaffer DM, Nelson V, Neri E. Assessing combined chemical exposures as risk factors for neural tube defects. Reprod Toxicol. 2001 Nov-Dec;15(6):631–5. [PubMed]
146. Rankin J, Chadwick T, Natarajan M, Howel D, Pearce MS, Pless-Mulloli T. Maternal exposure to ambient air pollutants and risk of congenital anomalies. Environ Res. 2009 Feb;109(2):181–7. [PubMed]
147. Hansen CA, Barnett AG, Jalaludin BB, Morgan GG. Ambient air pollution and birth defects in brisbane, australia. PLoS One. 2009;4(4):e5408. [PMC free article] [PubMed]
148. Parker SE, Mai CT, Strickland MJ, Olney RS, Rickard R, Marengo L, et al. Multistate study of the epidemiology of clubfoot. Birth Defects Res A Clin Mol Teratol. 2009 Nov;85(11):897–904. [PubMed]
149. Wong-Gibbons DL, Romitti PA, Sun L, Moore CA, Reefhuis J, Bell EM, et al. Maternal periconceptional exposure to cigarette smoking and alcohol and esophageal atresia +/- tracheo-esophageal fistula. Birth Defects Res A Clin Mol Teratol. 2008 Nov;82(11):776–84. [PubMed]
150. Felix JF, Jong EMd, Torfs CP, Klein Ad, Rottier RJ, Tibboel D. Genetic and environmental factors in the etiology of esophageal atresia and/or tracheoesophageal fistula: An overview of the current concepts. Birth Defects Research Part A: Clinical and Molecular Teratology. 2009;85(9):747–54. [PubMed]
151. Slickers JE, Olshan AF, Siega-Riz AM, Honein MA, Aylsworth AS. Maternal body mass index and lifestyle exposures and the risk of bilateral renal agenesis or hypoplasia: the National Birth Defects Prevention Study. Am J Epidemiol. 2008 Dec 1;168(11):1259–67. [PubMed]
152. Kistner EO, Shi M, Weinberg CR. Using cases and parents to study multiplicative gene-by-environment interaction. Am J Epidemiol. 2009 Aug 1;170(3):393–400. [PMC free article] [PubMed]
153. Verret C, Jutand MA, De Vigan C, Begassat M, Bensefa-Colas L, Brochard P, et al. Reproductive health and pregnancy outcomes among French gulf war veterans. BMC Public Health. 2008;8:141. [PMC free article] [PubMed]
154. Loffredo CA. Epidemiology of cardiovascular malformations: prevalence and risk factors. Am J Med Genet. 2000 Winter;97(4):319–25. [PubMed]
155. Varela MM, Nohr EA, Llopis-Gonzalez A, Andersen AM, Olsen J. Socio-occupational status and congenital anomalies. Eur J Public Health. 2009 Apr;19(2):161–7. [PMC free article] [PubMed]
156. Leong FT, Freeman LJ, Keavney BD. Fresh fields and pathways new: recent genetic insights into cardiac malformation. Heart. 2009 Mar;95(6):442–7. [PubMed]
157. Acs N, Banhidy F, Puho EH, Czeizel AE. Possible association between acute pelvic inflammatory disease in pregnant women and congenital abnormalities in their offspring: a population-based case-control study. Birth Defects Res A Clin Mol Teratol. 2008 Aug;82(8):563–70. [PubMed]
158. Kuehl KS, Loffredo CA. A cluster of hypoplastic left heart malformation in Baltimore, Maryland. Pediatr Cardiol. 2006 Jan-Feb;27(1):25–31. [PubMed]
159. Vaktskjold A, Talykova LV, Chashchin VP, Odland JO, Nieboer E. Maternal nickel exposure and congenital musculoskeletal defects. Am J Ind Med. 2008 Nov;51(11):825–33. [PubMed]
160. Zhu JL, Vestergaard M, Hjollund NH, Olsen J. Pregnancy outcomes among female hairdressers who participated in the Danish National Birth Cohort. Scand J Work Environ Health. 2006 Feb;32(1):61–6. [PubMed]
161. Zhu JL, Knudsen LE, Andersen AM, Hjollund NH, Olsen J. Laboratory work and pregnancy outcomes: a study within the National Birth Cohort in Denmark. Occup Environ Med. 2006 Jan;63(1):53–8. [PMC free article] [PubMed]
162. Zhu JL, Hjollund NH, Andersen AM, Olsen J. Occupational exposure to pesticides and pregnancy outcomes in gardeners and farmers: a study within the Danish National Birth Cohort. J Occup Environ Med. 2006 Apr;48(4):347–52. [PubMed]
163. Wennborg H, Magnusson LL, Bonde JP, Olsen J. Congenital malformations related to maternal exposure to specific agents in biomedical research laboratories. J Occup Environ Med. 2005 Jan;47(1):11–9. [PubMed]
164. Strickland MJ, Klein M, Correa A, Reller MD, Mahle WT, Riehle-Colarusso TJ, et al. Ambient air pollution and cardiovascular malformations in Atlanta, Georgia, 1986-2003. Am J Epidemiol. 2009 Apr 15;169(8):1004–14. [PMC free article] [PubMed]
165. Langlois PH, Brender JD, Suarez L, Zhan FB, Mistry JH, Scheuerle A, et al. Maternal residential proximity to waste sites and industrial facilities and conotruncal heart defects in offspring. Paediatr Perinat Epidemiol. 2009 Jul;23(4):321–31. [PubMed]
166. Vinceti M, Malagoli C, Fabbi S, Teggi S, Rodolfi R, Garavelli L, et al. Risk of congenital anomalies around a municipal solid waste incinerator: a GIS-based case-control study. Int J Health Geogr. 2009;8:8. [PMC free article] [PubMed]
167. Suarez L, Brender JD, Langlois PH, Zhan FB, Moody K. Maternal exposures to hazardous waste sites and industrial facilities and risk of neural tube defects in offspring. Ann Epidemiol. 2007 Oct;17(10):772–7. [PubMed]
168. Watson RE, Jacobson CF, Williams AL, Howard WB, DeSesso JM. Trichloroethylene-contaminated drinking water and congenital heart defects: a critical analysis of the literature. Reprod Toxicol. 2006 Feb;21(2):117–47. [PubMed]
169. Weselak M, Arbuckle TE, Wigle DT, Walker MC, Krewski D. Pre- and post-conception pesticide exposure and the risk of birth defects in an Ontario farm population. Reprod Toxicol. 2008 Aug;25(4):472–80. [PubMed]
170. Winchester PD, Huskins J, Ying J. Agrichemicals in surface water and birth defects in the United States. Acta Paediatr. 2009 Apr;98(4):664–9. [PMC free article] [PubMed]
171. Ochoa-Acuna H, Carbajo C. Risk of limb birth defects and mother's home proximity to cornfields. Sci Total Environ. 2009 Jul 15;407(15):4447–51. [PubMed]
172. Langlois PH, Scheuerle A, Horel SA, Carozza SE. Urban versus rural residence and occurrence of septal heart defects in Texas. Birth Defects Res A Clin Mol Teratol. 2009 Sep;85(9):764–72. [PubMed]
173. Batra M, Heike CL, Phillips RC, Weiss NS. Geographic and occupational risk factors for ventricular septal defects: Washington State, 1987-2003. Arch Pediatr Adolesc Med. 2007 Jan;161(1):89–95. [PubMed]
174. Nassar N, Abeywardana P, Barker A, Bower C. Parental occupational exposure to potential endocrine disrupting chemicals and risk of hypospadias in infants. Occup Environ Med. 2009 Nov 25; [PubMed]
175. Kalfa N, Philibert P, Sultan C. Is hypospadias a genetic, endocrine or environmental disease, or still an unexplained malformation? Int J Androl. 2009 Jun;32(3):187–97. [PubMed]
176. Nassar N, Bower C, Barker A. Increasing prevalence of hypospadias in Western Australia, 1980-2000. Arch Dis Child. 2007 Jul;92(7):580–4. [PMC free article] [PubMed]
177. Woodruff TJ, Grillo J, Schoendorf KC. The relationship between selected causes of postneonatal infant mortality and particulate air pollution in the United States. Environ Health Perspect. 1997 Jun;105(6):608–12. [PMC free article] [PubMed]
178. Dejmek J, Selevan SG, Benes I, Solansky I, Sram RJ. Fetal growth and maternal exposure to particulate matter during pregnancy. Environ Health Perspect. 1999 Jun;107(6):475–80. [PMC free article] [PubMed]
179. Pearce MS, Glinianaia SV, Rankin J, Rushton S, Charlton M, Parker L, et al. No association between ambient particulate matter exposure during pregnancy and stillbirth risk in the north of England, 1962-1992. Environ Res. 2010 Jan;110(1):118–22. [PMC free article] [PubMed]
180. Levario-Carrillo M, Amato D, Ostrosky-Wegman P, Gonzalez-Horta C, Corona Y, Sanin LH. Relation between pesticide exposure and intrauterine growth retardation. Chemosphere. 2004 Jun;55(10):1421–7. [PubMed]
181. Perera FP, Rauh V, Tsai WY, Kinney P, Camann D, Barr D, et al. Effects of transplacental exposure to environmental pollutants on birth outcomes in a multiethnic population. Environ Health Perspect. 2003 Feb;111(2):201–5. [PMC free article] [PubMed]
182. Whyatt RM, Rauh V, Barr DB, Camann DE, Andrews HF, Garfinkel R, et al. Prenatal insecticide exposures and birth weight and length among an urban minority cohort. Environ Health Perspect. 2004 Jul;112(10):1125–32. [PMC free article] [PubMed]
183. Berkowitz GS, Wetmur JG, Birman-Deych E, Obel J, Lapinski RH, Godbold JH, et al. In utero pesticide exposure, maternal paraoxonase activity, and head circumference. Environ Health Perspect. 2004 Mar;112(3):388–91. [PMC free article] [PubMed]
184. Eskenazi B, Harley K, Bradman A, Weltzien E, Jewell NP, Barr DB, et al. Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population. Environ Health Perspect. 2004 Jul;112(10):1116–24. [PMC free article] [PubMed]
185. Sagiv SK, Mendola P, Loomis D, Herring AH, Neas LM, Savitz DA, et al. A time-series analysis of air pollution and preterm birth in Pennsylvania, 1997-2001. Environ Health Perspect. 2005 May;113(5):602–6. [PMC free article] [PubMed]
186. Huynh M, Woodruff TJ, Parker JD, Schoendorf KC. Relationships between air pollution and preterm birth in California. Paediatr Perinat Epidemiol. 2006 Nov;20(6):454–61. [PubMed]
187. Grandjean P. Late insights into early origins of disease. Basic Clin Pharmacol Toxicol. 2008 Feb;102(2):94–9. [PMC free article] [PubMed]
  • Reference 2** presents an innovative approach to combining human vital statistics data to develop an integrated assessment of developmental disease)
  • Reference 8* a thoughtful, comprehensive review of the literature on environmental chemicals and reproductive and developmental health.
  • (Reference 11* review of our current understanding of paternal exposures and developmental diseases)
  • (Reference 12** analysis of methodological issues which need attention to improve our ability to assess reproductive and developmental impacts of environmental exposures)
  • (Reference 20** a frequently updated compilation of the concentrations of environmental chemicals found in humans in the US).
  • (Reference 31* provides a current review of genetic factors in preterm birth).
  • (Reference 40* provides a current review of cardiovascular defects with attention to recognition at birth and later in life, including postmortem diagnosis).
  • (Reference 50* provides a summary of issues in exposure characterization, methodological issues, health endpoint assessment and mode of action useful for thinking about design of epidemiological studies).
  • Reference 53* (good resource for literature and methodological approaches
  • Reference 56* (good resource for literature and methodological approaches
  • Reference 81** (the issue of race in developmental disease has a long and complicated history, the approach and analysis by Kramer and Hogue provides a superb analysis of our current understanding and limitations in understanding
  • Reference 82** (while it has been observed for some time that a relationship exists between preterm birth and developmental disease this analysis represents a good resource for literature and methodological approaches
  • Reference 112(** personnel monitoring, this paper is an excellent example of contemporary monitoring needed for careful assessment of individual exposure)
  • Reference 113(* provides a good description of an approach to evaluate trimester of exposure on growth)
  • Reference 124(* demonstration of benefit of personal monitoring rather than ecological exposure estimation)
  • Reference 128 Reference ** demonstrating benefit of biomarker exposure characterization and ongoing utility of birth cohort studies with tissue samples available for measure of genetic and exposure biomarkers).
  • (Reference 130 ** provides the framework for a well designed exposure assessment in a drinking water pollution and fetal growth study)
  • Reference 131** (represents an excellent example of the utility of a birth cohort to explore an innovative question, maternal blood lead and pregnancy associated hypertension, and open a new area for scientific inquiry)
  • Reference 133 * an innovative question and methods exploring prenatal exposures and postnatal lung function
  • Reference 170* ecological analysis of atrazine, nitrates and other pesticides in surface water provides a fascinating starting point for more detailed analysis of agricultural chemical exposures to broad human populations and birth defects.